Cord Blood America Enters Agreement With BancoVida, a Cord Blood Collection Company in San Juan, Puerto Rico
LAS VEGAS, Aug. 29, 2011 /PRNewswire/ — Cord Blood America, Inc. (OTC Bulletin Board: CBAI) announced today it has entered into an agreement with BancoVida (www.bancovida.com) to offer umbilical cord blood collection services in Puerto Rico and throughout the Caribbean.
The partnership will allow BancoVida and Cord Blood America to educate prospective parents in Puerto Rico and the Caribbean on the value of storing their baby’s umbilical cord blood. The stem cells will be stored at Cord Blood America’s state-of-the-art facility in Las Vegas.
“We are very excited about our partnership with BancoVida and for the opportunity to assist them in bringing this potentially life-saving service to an underserved area,” said Gabby Stinson, Cord Blood America Project Manager.
Cord blood stem cells, which are collected at birth in a non-invasive procedure, are currently used to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies. Various studies and clinical trials are currently underway to determine the effectiveness of stem cells in treating some of the most serious diseases, such as diabetes, heart disease, Parkinson’s and cerebral palsy for which there is no known cure.
BancoVida Corp. has been established to develop and market private cord blood banking services to patients in Puerto Rico and the Caribbean. Our mission is to successfully introduce and become the leader of private cord blood banking in the Caribbean. BancoVida is the exclusive reseller of cord blood banking services for Cord Blood America and CorCell in Puerto Rico and the Caribbean. To find out more about BancoVida, visit our website at www.bancovida.com.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI.ob) is the parent company of CorCell Companies, Inc., which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board:CBAI.ob), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
E & E Communications
SOURCE Cord Blood America, Inc.